Rani Therapeutics Holdings, Inc.
RANI
$0.84
-$0.03-3.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.53% | 1.20% | 1.15% | -0.52% | 2.93% |
| Total Depreciation and Amortization | -28.94% | -21.44% | -12.45% | -0.91% | 7.17% |
| Total Amortization of Deferred Charges | -60.78% | -35.78% | -10.78% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 478.35% | 235.33% | 146.72% | 95.87% | 84.64% |
| Change in Net Operating Assets | 350.55% | 455.57% | 1,379.04% | 93.84% | 79.16% |
| Cash from Operations | 34.56% | 50.17% | 47.28% | 29.64% | 31.41% |
| Capital Expenditure | 80.74% | 82.72% | 67.16% | 70.54% | 67.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -276.37% | -198.62% | -134.58% | -14.16% | -36.09% |
| Cash from Investing | -278.14% | -199.87% | -135.49% | -13.41% | -35.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.78% | -93.97% | -314.44% | -1,100.00% | -- |
| Issuance of Common Stock | 459.68% | 490.69% | 488.58% | 61.69% | 5,133.04% |
| Repurchase of Common Stock | -27.78% | 2.86% | -25.53% | -23.68% | -1.89% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -157.02% | -157.02% | -157.02% | 27.48% | -- |
| Cash from Financing | 540.31% | 352.11% | 196.65% | -86.77% | 2,302.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -199.05% | -123.72% | 792.48% | 80.86% | 287.69% |